Healthcare ❯Pharmaceuticals ❯Drug Pricing

Pharmacy Benefit Managers

FTC Report Insulin Pricing Regulatory Practices Market Share Healthcare Reform

Cuban and Trump Jr. Unite in Blaming PBMs for Soaring Drug Costs

Their public agreement underscores growing bipartisan support for reforms to curb middlemen’s grip on prescription prices.

AbbVie Reports Strong Sales Growth for Skyrizi and Rinvoq, Boosts 2027 Revenue Outlook

FTC Report Reveals $7.3 Billion in Drug Markups by Leading PBMs